Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
Revista Latinoamericana de Hipertension(4)
American Journal of Therapeutics(2)
Current Pharmaceutical Design(1)
Medicina Clinica(1)
Área temáticas
Enfermedades(7)
Farmacología y terapéutica(4)
Fisiología humana(3)
Medicina y salud(3)
Historia de América del Norte(1)
Increased levels of lipoprotein (a) are related to family risk factors of cardiovascular disease in children and adolescents from Maracaibo, Venezuela
ArticleAbstract: The aims of this study were to determine Lipoprotein (a) [Lp(a)] concentrations in a sample of subjePalabras claves:adolescents, CHILDREN, CVD risk factors, Family history, Lipoprotein (a)Autores:Almarza J., Cano-Peñaloza R., Cano-Ponce C., García-Camacho D., Hernández-Hernandez R., Israili Z.H., Mengual-Moreno E., Sorell L.T., Souki-Rincón A., Torres D., Urdaneta J., Valmore Bermúdez, Velasco M.Fuentes:scopusMalondialdehide and reduced glutathione increase in patients with chronic stable ischaemic cardiopathy
ArticleAbstract: BACKGROUND AND OBJECTIVE: Cardiovascular diseases are associated with the ischemia/reperfusion phenoPalabras claves:Chronic ischemic heart disease, Coronary disease, Oxidation/antioxidationAutores:Bermúdez-Arias F., Cabrera De Bravo M.C., Cano-Ponce C., Leal-Gonzalez E., Mengual-Moreno E., Valmore BermúdezFuentes:scopusPhytotherapy for cardiovascular disease: A bench-to-bedside approach
ReviewAbstract: At present, cardiovascular disease (CVD) remains the leading cause of morbidity and mortality world-Palabras claves:atherosclerosis, Cardiovascular disease, dyslipidemia, Hypertension, Medicinal herbs, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Ortega A., Pírela D., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusLipoprotein (a): Molecular and Epidemiologic basis about its role in cardiovascular diseases
ReviewAbstract: In 1963, Kare Berg at the University of Oslo discovered Lp(a) as a new human plasmatic antigen set.Palabras claves:Apolipoprotein(a), Atherogenesis, Cardiovascular disease, lipoprotein(a), Lp (a), thrombogenesisAutores:Aparicio D., Arráiz N., Canelón R., Cano-Ponce C., Cizcek A., Faria J., Gotera D., Guerra-Torres X.E., Manuel V., Rojas E.R., Sorell L.T., Valmore BermúdezFuentes:scopusLipoprotein(a): From molecules to therapeutics
ReviewAbstract: Lipoprotein (a) [Lp(a)] was discovered by Kare Berg in 1963 from the study of low-density lipoproteiPalabras claves:Atherogenesis, Cardiovascular disease, Hyperlipoproteinemia(a), lipoprotein(a), therapeuticsAutores:Amell A., Aparicio D., Arráiz N., Cabrera M., Canelón R., Cano R.A., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Mengual-Moreno E., Reyna-Villasmil N., Rojas E.R., Sorell L.T., Valmore Bermúdez, Velasco M.Fuentes:scopusSerum levels of lipoprotein(a) and its behavior in the state of Zulia: 10 Years of research
ReviewAbstract: Lipoprotein Lp(a) is considered one of the most important independent risk factors for atherosclerotPalabras claves:Cardiovascular disease, Coronary artery disease, Hormone replacement therapy, lipoprotein(a), myocardial infarction, Physical activity, risk factorAutores:Amell A., Añez-Ramos R., Arias F.B., Arráiz N., Cabrera M., Cano-Ponce C., Cruz S., González M.C., Mejías J.C., Mengual-Moreno E., Nava A., Rojas-Quintero J., Silva C., Sorell G L., Souki-Rincón A., Toledo A.C., Torres W., Torres Y., Valmore BermúdezFuentes:scopusSerum lipoprotein (a) in patients post myocardial infarction
ArticleAbstract: Lipoprotein (a) [Lp (a)] is considered an independent risk factor for cardiovascular disease. In ourPalabras claves:Abdominal circumference, body mass index, dyslipidemia, Lipoprotein (a), myocardial infarctionAutores:Amell A., Añez-Ramos R., Arráiz N., Cano-Ponce C., Carem Prieto, Carrillo M., Cruz S., González M.C., Joselyn Zula, Montiel M., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Vergara P.M.Fuentes:googlescopusPrevalence of different lipid profile abnormalities in the consultation of cardiovascular risk factors from the "Dr. Félix Gómez" Endocrine and Metabolic Diseases Research Center in the period from January 2006 to January 2007
ArticleAbstract: Objective: Isolated (or mixed with other dyslipidemias) low HDLc levels are risk factors for coronarPalabras claves:Cardiovascular disease, dyslipidemia, Low isolated HDLc, PREVALENCEAutores:Cano-Ponce C., Luti Y., Mengual-Moreno E., Sánchez D., Scott G., Valmore Bermúdez, Velasco M.Fuentes:scopus